Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Apex Global Brands Inc (APEX)

Apex Global Brands Inc (APEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
APEX GLOBAL INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apex Global Brands Inc. - APEX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Apex Global Brands Inc. (OTC: APEX) to Galaxy...

APEX : 1.9350 (-0.26%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Apex Global Brands Inc. Buyout

WILMINGTON, Del., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Apex Global Brands Inc. (“Apex”) (OTC: APEX ) regarding possible breaches of fiduciary...

APEX : 1.9350 (-0.26%)
Apex Global Brands Announces Agreement to Be Acquired by Galaxy Universal LLC for $2.00 Per Share in All Cash Deal

Acquisition is expected to close in the second quarter of 2021

APEX : 1.9350 (-0.26%)
Apex Global Brands Reports Third Quarter 2021 Financial Results

Third Quarter Fiscal 2021 Highlights versus Third Quarter Fiscal 2020:

APEX : 1.9350 (-0.26%)

Barchart Exclusives

2 ‘Monster’ Stocks to Snap Up Before 2025
Analysts at Jefferies have identified Metagenomi and Structure Therapeutics as two "monster" stocks in the biotech sector, with potential gains of up to 1,000%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar